Reporting owner · Q3 2026 · CIK 2009762

Budur Kumar: insider trades.

Budur Kumar reported 15 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($3.1M), across 1 company.

Transactions
15
Purchases (P)
0
Sales (S)
7
Companies
1
Name as filed
Budur Kumar

Companies

CompanyRelationshipTransactions
Harmony Biosciences Holdings, Inc. (HRMY)Officer · CHIEF MEDICAL OFFICER15

Transactions

15 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-18Harmony Biosciences Holdings, Inc.M10,406$30.6923,521Form 4
2026-09-18Harmony Biosciences Holdings, Inc.S35,852$43.0513,115Form 4
2026-09-18Harmony Biosciences Holdings, Inc.M25,446$30.2748,967Form 4
2026-09-17Harmony Biosciences Holdings, Inc.M400$30.6913,515Form 4
2026-09-17Harmony Biosciences Holdings, Inc.M400$30.2713,915Form 4
2026-09-17Harmony Biosciences Holdings, Inc.S800$4313,115Form 4
2026-09-16Harmony Biosciences Holdings, Inc.S1,800$43.0113,115Form 4
2026-09-16Harmony Biosciences Holdings, Inc.M900$30.2714,915Form 4
2026-09-16Harmony Biosciences Holdings, Inc.M900$30.6914,015Form 4
2026-09-08Harmony Biosciences Holdings, Inc.M10,754$30.2736,069Form 4
2026-09-08Harmony Biosciences Holdings, Inc.S22,954$43.113,115Form 4
2026-09-08Harmony Biosciences Holdings, Inc.M12,200$30.6925,315Form 4
2026-09-08Harmony Biosciences Holdings, Inc.S1,000$42.7913,115Form 4
2026-09-08Harmony Biosciences Holdings, Inc.S4,500$42.2514,115Form 4
2026-09-04Harmony Biosciences Holdings, Inc.S5,500$41.9818,615Form 4

Questions

What stock did Budur Kumar buy or sell?

Budur Kumar reported 15 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($3.1M), across 1 company.

Is Budur Kumar the same person as other filers with this name?

This page covers SEC CIK 2009762 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/budur-kumar-2009762.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.